SCHEMBL5556972

SCHEMBL5556972

Clc1ccc2c(c1)N=C(N1CCNC(Cc3ccccc3)C1)c1ccccc1N2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 17/20 0.64
DRD1 P21728 11/20 0.64
CHRM1 P11229 3/20 0.64
CYP1A2 P05177 2/20 0.64
CHRM2 P08172 2/20 0.64
CHRM4 P08173 2/20 0.64
CYP3A4 P08684 2/20 0.64
CHRM5 P08912 2/20 0.64
CYP2D6 P10635 2/20 0.64
CHRM3 P20309 2/20 0.64
KCNH2 Q12809 2/20 0.64
MTOR P42345 1/20 0.64
DRD3 P35462 3/20 0.58
HRH4 Q9H3N8 2/20 0.58
DRD5 P21918 2/20 0.58
HRH1 P35367 2/20 0.58
HRH3 Q9Y5N1 2/20 0.58
DRD4 P21917 2/20 0.58
HTR3E A5X5Y0 1/20 0.58
MEN1 O00255 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5556973 1.00 DRD2 (0.64) DRD2DRD1CHRM1CYP1A2CHRM2
SCHEMBL14511284 0.84 DRD2 (0.72) DRD2DRD1CHRM1CYP1A2CHRM2
SCHEMBL3414150 0.84 DRD2 (0.72) DRD2DRD1CHRM1CYP1A2CHRM2
SCHEMBL3408973 0.83 DRD2 (0.68) DRD2DRD1CHRM1CYP1A2CHRM2
N-Desmethylclozapine SCHEMBL30416482 0.79 DRD2 (1.00) DRD2DRD1CHRM1CYP1A2CHRM2
N-Desmethylclozapine SCHEMBL29365906 0.79 DRD2 (1.00) DRD2DRD1CHRM1CYP1A2CHRM2
N-Desmethylclozapine SCHEMBL781423 0.79 DRD2 (1.00) DRD2DRD1CHRM1CYP1A2CHRM2
N-Desmethylclozapine SCHEMBL29360816 0.79 DRD2 (1.00) DRD2DRD1CHRM1CYP1A2CHRM2
SCHEMBL20887469 0.79 DRD2 (0.88) DRD2DRD1CHRM1CYP1A2CHRM2
SCHEMBL3409655 0.79 DRD2 (0.67) DRD2DRD1CHRM1CYP1A2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1492794-B1 PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS LILLY CO ELI (US) 2007-12-12 EP disclosed
US-7214673-B2 For therapy of psychosis and bipolar disorder ELI LILLY AND COMPANY (US) 2007-05-08 US disclosed